Rundu Co., Ltd. (002923.SZ) plans to pay 2 yuan for 10 shares to be deducted from interest on May 31

Rundu Co., Ltd. (002923.SZ) announced that the company's 2023 equity distribution plan: to all shareholders every 10...

Zhitong FinanceMay 26 03:51 ET

There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings

The market was pleased with the recent earnings report from Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE:002923), despite the profit numbers being soft. We think that investors might be looking at som

Simply Wall StMay 4 21:41 ET

Rundu Co., Ltd. (002923.SZ): Net profit of 29.055,800 yuan in the first quarter decreased by 28.14% year-on-year

On April 26, Ge Longhui Co., Ltd. (002923.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 306 million yuan, down 14.82% year on year; net profit attributable to shareholders of listed companies was 29.0558 million yuan, down 28.14% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 255.725 million yuan, down 29.80% year on year; basic earnings per share were 0.09 yuan.

Gelonghui FinanceApr 26 09:06 ET

Rundu Co., Ltd. (002923.SZ): The product application range covers various fields such as peptic ulcer, hypertension, surgical anesthesia, antipyretic analgesia, anti-infective, and diabetes

Gelonghui, April 9 | Rundu Co., Ltd. (002923.SZ) said on the investor interactive platform that the company is a modern technology-based pharmaceutical enterprise integrating drug R&D, production and sales. Its main business is R&D, production and sales of chemical preparations, chemical raw materials, pharmaceutical intermediates. The product application range covers peptic ulcers, hypertension, surgical anesthesia, antipyretic analgesia, anti-infective, diabetes, etc. Nicotine is a new business field that the company has expanded in recent years, and has now formed a certain level of commercial sales. The company will actively adjust the strategic plan according to the market environment to seek more opportunities for commercial cooperation

Gelonghui FinanceApr 9 05:35 ET

Rundu Co., Ltd. (002923.SZ): Reganosheng obtained a notice of approval for the marketing application of chemical raw materials

Gelonghui, March 29 | Rundu Co., Ltd. (002923.SZ) announced that the company recently received the approval and issuance of Reganosin (hereinafter referred to as “this product”) “Notice of Approval of the Marketing Application for Chemical Ingredients” from the China Drug Administration. This product is an important part of the company's industrial chain in the field of cardiac stress medication. With the application and promotion of cardiac stress drugs in the field of coronary heart disease diagnosis, it is expected to benefit more patients.

Gelonghui FinanceMar 29 05:48 ET

Optimistic Investors Push Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE:002923) Shares Up 25% But Growth Is Lacking

Those holding Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE:002923) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to repair the rece

Simply Wall StMar 22 19:07 ET